ES
Eric Schmidt Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
41%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
80%
Neutral
20%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $74 |
210%
upside
| 3 | -18% |
0
%
| 17 Dec ‘25 4 months ago |
|
|
|
Overweight
Assumed
| – | – | 1 | -39% |
0
%
| 16 Oct ‘25 6 months ago |
|
|
|
Neutral
Assumed
| $88 |
23%
downside
| 1 | – |
–
| 9 Oct ‘25 6 months ago |
|
|
|
Overweight
Reiterated
| – | – | 3 | -0.33% |
0
%
| 8 Sep ‘25 7 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | -0.92% |
0
%
| 17 Jul ‘25 9 months ago |
|
|
|
Overweight
Reiterated
| $96 |
32%
upside
| 1 | +144% |
0
%
| 27 Jun ‘25 10 months ago |
|
|
|
Neutral
Reiterated
| – | – | 1 | -62% |
–
| 20 Jun ‘25 10 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | +772% |
0
%
| 10 Jun ‘25 10 months ago |
|